Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1921-2016Class II

Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection...

Remel Inc / initiated 2016-03-24 / Terminated

Remel Inc began a recall of Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in... on . FDA classified it as Class II and gives the reason as "Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1921-2016
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Remel Inc
Product
Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in vitro diagnostic
Product code
JTT Susceptibility Test Powders, Antimicrobial
Reason for recall
Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting.
FDA root cause
Under Investigation by firm
Action
Customers were notified by letter beginning on March 24, 2016.
Quantity in commerce
2 units were imported and distributed domestically
Distribution
US distribution in MO.
Product codes and lots
Lot 1717357 Exp: 31Aug2017

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1921-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1921-2016Class IITerminatedVoluntary: Firm initiated